Safety of praziquantel in persons with and without schistosomiasis: systematic review and meta-analysis
View ORCID ProfileAnthony Danso-Appiah, View ORCID ProfileDavid Owiredu, View ORCID ProfileMorrison Asiamah, View ORCID ProfileKwadwo Akuffo, View ORCID ProfilePaolo Eusebi, Guo Jiangang, Pauline Mwinzi, View ORCID ProfileDaniel G. Colley, Paul Hagan, View ORCID ProfileM. Hassan Murad, Amadou Garba Djirmay
doi: https://doi.org/10.1101/2022.03.09.22270839
Anthony Danso-Appiah
1UG Centre for Evidence Synthesis and Policy (UGCESP), School of Public Health, P. O. Box LG13, Legon, Accra, Ghana
2Department of Epidemiology and Disease Control, School of Public Health, University of Ghana, Legon, Accra, Ghana
David Owiredu
2Department of Epidemiology and Disease Control, School of Public Health, University of Ghana, Legon, Accra, Ghana
Morrison Asiamah
2Department of Epidemiology and Disease Control, School of Public Health, University of Ghana, Legon, Accra, Ghana
Kwadwo Akuffo
3Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
Paolo Eusebi
4Health Planning Service, Regional Health Authority of Umbria, Italy 4Department of Medicine, University of California, San Francisco, United States
Guo Jiangang
5WHO Department of Control of Neglected Tropical Diseases, Geneva, Switzerland
Pauline Mwinzi
6Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN), WHO Regional Office for Africa Brazzaville, Congo
Daniel G. Colley
7Center for Tropical and Emerging Global Diseases, University of Georgia, Room 330B -Coverdell Center, 500 D.W. Brooks Drive -30602 - Athens Georgia, United States
Paul Hagan
8Faculty of Health Sciences, University of Hull, Hull, UK
M. Hassan Murad
9The Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, Minnesota, USA
Amadou Garba Djirmay
5WHO Department of Control of Neglected Tropical Diseases, Geneva, Switzerland
Data Availability
All data produced in the present work are contained in the manuscript.
Posted March 12, 2022.
Safety of praziquantel in persons with and without schistosomiasis: systematic review and meta-analysis
Anthony Danso-Appiah, David Owiredu, Morrison Asiamah, Kwadwo Akuffo, Paolo Eusebi, Guo Jiangang, Pauline Mwinzi, Daniel G. Colley, Paul Hagan, M. Hassan Murad, Amadou Garba Djirmay
medRxiv 2022.03.09.22270839; doi: https://doi.org/10.1101/2022.03.09.22270839
Safety of praziquantel in persons with and without schistosomiasis: systematic review and meta-analysis
Anthony Danso-Appiah, David Owiredu, Morrison Asiamah, Kwadwo Akuffo, Paolo Eusebi, Guo Jiangang, Pauline Mwinzi, Daniel G. Colley, Paul Hagan, M. Hassan Murad, Amadou Garba Djirmay
medRxiv 2022.03.09.22270839; doi: https://doi.org/10.1101/2022.03.09.22270839
Subject Area
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (185)
- Cardiovascular Medicine (2772)
- Dermatology (237)
- Emergency Medicine (415)
- Epidemiology (12423)
- Forensic Medicine (10)
- Gastroenterology (786)
- Genetic and Genomic Medicine (4289)
- Geriatric Medicine (396)
- Health Economics (703)
- Health Informatics (2770)
- Health Policy (1025)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (405)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4066)
- Nursing (218)
- Nutrition (602)
- Oncology (2145)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (78)
- Pathology (479)
- Pediatrics (1151)
- Primary Care Research (471)
- Public and Global Health (6671)
- Radiology and Imaging (1457)
- Respiratory Medicine (888)
- Rheumatology (425)
- Sports Medicine (353)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (171)